TMFUltraLong

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and in investment planning topics. You'll usually find him writing about Obamacare, marijuana, developing drugs, diagnostics, and medical devices, Social Security, taxes, or any number of other macroeconomic issues.

TMFUltraLong’s Activity

Thu May 21

NL

Article

TMFUltraLong published an article 12:00 AM

5 Reasons Your Health Insurance Premium Will Likely Rise in 2016

If you don't want to pay more for health insurance, look away now! Here are five reasons why you should be prepared to pay more per month for your health insurance plan in 2016.

Wed May 20

NL

Article

TMFUltraLong published an article 12:00 AM

"Robin Hood Tax" Aims for Free College Education at Wall Street's Expense

Senator Bernie Sanders introduces two potentially game-changing bills in Congress, one of which would make a college education free.

NL

Article

TMFUltraLong published an article 12:00 AM

Is Massachusetts' Medical Marijuana Industry Going Up in Smoke?

Legal marijuana use may be expanding nationwide, but the Massachusetts medical marijuana industry is simply struggling to get its feet off the ground.

Tue May 19

NL

Article

TMFUltraLong published an article 12:00 AM

Hypothetically, Here's What Might Happen to Marijuana Prices if it Were Legalized

A look at the economic angle behind marijuana prices and what current per ounce prices can teach us about the industry.

NL

Article

TMFUltraLong published an article 12:00 AM

What Might Happen if Obamacare's "King vs. Burwell" Challenge Is Upheld?

The Supreme Court has heard arguments from both sides in "King vs, Burwell," and is set to make its decision in a matter of weeks. Find out what might happen if the High Court finds in favor of the plaintiffs.

Mon May 18

NL

Article

TMFUltraLong published an article 3:11 PM

Why Idera Pharmaceuticals Inc. Shares Vaulted Higher

Idera Pharmaceuticals' stock rockets higher after announcing fresh data on one of its clinical compounds -- but should you be buying?

NL

Article

TMFUltraLong published an article 12:00 AM

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

NL

Article

TMFUltraLong published an article 12:00 AM

This Issue Is Set to Dominate the 2016 Elections

Gallup asked, and people answered -- this is the issue poised to dominate the 2016 presidential elections. Here's what you need to know.

NL

Article

TMFUltraLong published an article 12:00 AM

The Smart Way to Double Your Money in Retirement

The Great Recession ransacked many Americans' retirement savings, but there's a smart investment vehicle retirees can use right now that can double their money during retirement.

Fri May 15

NL

Article

TMFUltraLong published an article 12:00 AM

Following Hepatitis C, This Could Be the Next Disease Researchers Cure

With an effective cure for hepatitis C now in place after decades of research, we asked three of our top healthcare analysts which disease they believed researchers may cross off the list next. Here's what they had to say.

NL

Article

TMFUltraLong published an article 12:00 AM

How 7 States Wasted Nearly $1.3 Billion in Federal Money on Obamacare

With little accountability, these seven states burned through close to $1.3 billion in federal grant money from the Department of Health and Human Services.

NL

Article

TMFUltraLong published an article 12:00 AM

Why 1 Wall Street Firm Dropped the Hammer on Cisco Systems Inc.

Cisco Systems delivered 12% adjusted profit growth in the third quarter, but that wasn't good enough to persuade one Wall Street firm to hold its rating steady on the stock.

Thu May 14

NL

Article

TMFUltraLong published an article 12:00 AM

Could an HIV/AIDS Vaccine Be a Reality By the End of the Decade?

New research at one California university leads to the hope of a possible effective HIV cure.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Types of Risk Facing Gold Stocks

They may look lustrous, but gold stocks aren't without risk, even after suffering through four very weak years. Here are three big risks facing gold stocks.

Wed May 13

NL

Article

TMFUltraLong published an article 12:00 AM

3 Types of Risks Facing Biotech Stocks

Biotech stocks have been dramatically outperforming the broader market, but that doesn't mean they're free of risk. Here are three types of risks all biotech stocks face.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Ways Personalized Medicine Could Completely Transform Your Life

The one-size-fits-all doctor-patient relationship that's existed for decades is slowly dying. Instead, an array of new personalized interactions, along with diagnostics, devices, and therapies, are taking its place.

Tue May 12

NL

Article

TMFUltraLong published an article 3:24 PM

Why It's Lights Out for Orexigen Therapeutics, Inc.

Orexigen Therapeutics shares tumble after the company announces the termination of a critical post-marketing approval study for Contrave.

NL

Article

TMFUltraLong published an article 12:00 AM

The Marijuana Movement Gains Its Most Star-Studded Supporter Yet

Morgan Freeman may have just become the face of the marijuana movement, but is his fame going to be enough to finally lift marijuana into the forefront?

NL

Article

TMFUltraLong published an article 12:00 AM

Bad News America: Social Security Is in Worse Shape Than You Thought

Nearly everyone knows that the Social Security system is in trouble, but these two recently released studies from a well-respected post-secondary institution suggest the social program is in significantly worse shape than anyone suspects.

Mon May 11

NL

Article

TMFUltraLong published an article 12:00 AM

How Dollar-Cost Averaging Can Make You Rich

With three big advantages in its sails, dollar-cost averaging could be your ticket to a comfortable retirement.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.87
Player Rank 96 out of 75237
Score 8855.71
Score Change Today -1585.67
Accuracy 88.13%
Active Picks 105
Total Picks 506
Best Pick FAZ (+315.40)
Worst Pick PCYC (-8880.85)
Average Score per Pick 17.64
Charms Earned 16
Highest Rated Favorite TMFBabo
Go to TMFUltraLong’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 3
Recs Received 11
People who have rec'd these posts 11
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board CAPS Feedback
Very First Post Tickering....Just a heads up... (10/14/2010)
Percentage of Posts Rec'd 100.00 %
Show TMFUltraLong’s 10 Latest Posts